Upgrade to SI Premium - Free Trial

Astellas Pharma Inc Unsponsored Adr (ALPMY)

13.30 -0.24 (1.77%)

Chart
Today 6M 1Y 5Y

Latest Headlines

Astellas Pharma Inc (4503:JP) (ALPMY) PT Lowered to JPY2,600 at Macquarie May 28, 2026 10:37 AM - StreetInsider Astellas Announces Five-Year Corporate Strategic Plan to Deliver Greater VALUE Faster for Patients and Position Itself as a Sustainable Growth Company May 26, 2026 2:45 AM - PR NewsWire Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026 May 18, 2026 8:01 AM - PR NewsWire "Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies May 14, 2026 10:55 AM - Globe NewsWire Astellas reports IZERVAY reduced driving eligibility loss risk in eye disease study May 12, 2026 9:04 AM - StreetInsider IZERVAY® (avacincaptad pegol intravitreal solution) Demonstrated Increased Probability of Maintaining Driving Eligibility in Geographic Atrophy Patients May 12, 2026 9:01 AM - PR NewsWire Astellas Pharma Inc (4503:JP) (ALPMY) PT Lowered to JPY2,400 at Citi May 4, 2026 12:59 AM - StreetInsider Astellas Pharma Inc (4503:JP) (ALPMY) PT Lowered to JPY2,400 at Citi May 1, 2026 7:15 AM - StreetInsider Astellas to Highlight New Findings for Geographic Atrophy at ARVO 2026 Annual Meeting April 30, 2026 9:01 AM - PR NewsWire FDA grants priority review to Astellas-Pfizer cancer drug application April 20, 2026 6:45 AM - StreetInsider U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility April 20, 2026 6:45 AM - PR NewsWire Astellas Pharma Inc (4503:JP) (ALPMY) PT Lowered to JPY2,450 at Goldman Sachs April 15, 2026 8:15 AM - StreetInsider Astellas Pharma Inc (4503:JP) (ALPMY) PT Raised to JPY2,500 at JPMorgan March 23, 2026 6:29 AM - StreetInsider Jefferies Upgrades Astellas Pharma Inc (4503:JP) (ALPMY) to Buy March 23, 2026 4:29 AM - StreetInsider Astellas Pharma Inc (4503:JP) (ALPMY) PT Raised to JPY2,800 at Macquarie March 17, 2026 6:41 AM - StreetInsider Astellas Pharma Inc (4503:JP) (ALPMY) PT Raised to JPY2,200 at Bernstein SocGen Group March 12, 2026 8:24 AM - StreetInsider Full Article List